Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Directs federal action to address diseases affecting poor populations worldwide.
The problem
Neglected tropical diseases and poverty-related illnesses disproportionately affect low-income populations globally but receive limited research funding and policy attention compared to other diseases.
The proposal
Establishes coordinated federal efforts to research, prevent, and treat diseases of poverty through agency coordination, funding mechanisms, and international partnership initiatives.
The impact
Affects public health agencies, researchers, low-income populations in developing nations, and pharmaceutical companies working on treatments for neglected diseases.
Focuses resources on diseases affecting the world's poorest populations who have limited access to treatment. Could save millions of lives in developing countries. Aligns with humanitarian health goals.
Preventing neglected diseases reduces healthcare costs globally and improves productivity in affected regions. Can create economic benefits through healthier populations able to work and contribute.
Promotes U.S. leadership in global health partnerships and diplomatic relationships with developing nations. Can enhance America's soft power and international standing.
Federal coordination and funding may attract private sector investment in treatments for neglected diseases. Could spur innovation in medical research and biotechnology.
Bill provides no summary detailing specific funding amounts or budget impacts. Unclear how much taxpayer money will be spent or which agencies receive resources.
Focuses primarily on diseases affecting poor populations abroad rather than domestic health needs. May be viewed as prioritizing international aid over American healthcare concerns.
No official summary makes it difficult to assess specific mechanisms, timelines, or effectiveness measures. Lacks clarity on how coordination will occur between federal agencies.
Without detailed metrics or oversight requirements, may be difficult to measure success or ensure effective use of resources. Could face challenges in demonstrating results to taxpayers.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
No donor data found for current cycle
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.